Indeed, it has been shown that IL‐1β by intra‐tumoral injections is sufficient to cause CD8+ T cell‐mediated tumor regression in models of adenocarcinoma, melanoma, and sarcoma.251. This evidence concerns the gene CD8A and melanoma.